TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novavax AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 141,170 | 95,913 | 39,370 |
Financial expenses | 69,397 | 41,934 | 21,076 |
Earnings before taxes | 46,565 | -10,909 | -1,166 |
EBITDA | 48,255 | -9,826 | -520 |
Total assets | 336,782 | 351,398 | 256,368 |
Current assets | 237,002 | 251,164 | 158,354 |
Current liabilities | 149,274 | 203,418 | 125,689 |
Equity capital | 187,508 | 147,980 | 130,680 |
- share capital | 4 | 5 | 5 |
Employees (average) | 167 | 0 | 57 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 55.7% | 42.1% | 51.0% |
Turnover per employee | 845 | 691 | |
Profit as a percentage of turnover | 33.0% | -11.4% | -3.0% |
Return on assets (ROA) | 34.4% | 8.8% | 7.8% |
Current ratio | 158.8% | 123.5% | 126.0% |
Return on equity (ROE) | 24.8% | -7.4% | -0.9% |
Change turnover | 53,027 | 57,272 | 36,710 |
Change turnover % | 60% | 148% | 1380% |
Chg. No. of employees | 167 | -57 | 13 |
Chg. No. of employees % | -100% | 30% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.